clinical trial · NCT02354235
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)
Type 2 Diabetes MellitusTeneligliptinCanagliflozinPlacebo
brief summary
The purpose of this study is to evaluate the efficacy and safety of co-administration of Teneligliptin (MP-513) and Canagliflozin (TA-7284) once daily for 24 weeks in Japanese patients with Type 2 diabetes mellitus who are receiving treatment with Teneligliptin and have inadequate glycemic control.
started
Jan 1, 2015
primary completion
Jan 1, 2016
completion
Jan 1, 2016
last updated
Jan 7, 2026
official title
Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin in Patients With Inadequate Glycemic Control on Teneligliptin)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol